• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Myriad Genetics Inc

+ Add to Watchlist


37.9700 USD 0.3600 0.94%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Myriad Genetics Inc (MYGN)

Open: 38.4100 Day's Range: 37.6200 - 38.9800 Volume: 2,095,794
Previous Close: 38.3300 52wk Range: 20.0200 - 42.4960 1-Yr Rtn: +32.81%

Stock Chart for MYGN

No chart data available.
  • MYGN:US 37.9700
  • 1D
  • 1M
  • 1Y
Interactive MYGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYGN

Current P/E Ratio (ttm) 16.2961
Estimated P/E(06/2014) 17.2669
Relative P/E vs. SPX 0.9476
Earnings Per Share (USD) (ttm) 2.3300
Est. EPS (USD) (06/2014) 2.1990
Est. PEG Ratio 1.1283
Market Cap (M USD) 2,770.84
Shares Outstanding (M) 72.97
30 Day Average Volume 2,184,200
Price/Book (mrq) 4.1552
Price/Sale (ttm) 4.0474
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYGN

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Peter D MeldrumPresident/CEO/Co-FounderJames S EvansCFO/Treasurer
Robert Gardner HarrisonChief Information OfficerJerry S LanchburyChief Scientific Officer
More Company Profile & Key Executives for MYGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil